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1. Introduction 
Human Malaria is still a serious problem in sub-Saharan Africa and the risk exists 
throughout the region. It is a real fact that most malaria cases and deaths occur in sub-
Saharan Africa. This region has some of the poorest countries of the world with 90% of 
deaths occurring (approximately 3,000 deaths each day) [1]. The disease remains one of the 
leading causes of morbidity and mortality in the tropics. It is the most important and 
widespread of the tropical deadly diseases.  
It exacts a heavy toll of illness and death on children and pregnant women [2].  
In 2008, there were 247 million cases of malaria and nearly one million deaths – mainly 
among children living in sub-Saharan Africa [3]. A child dies every 45 second as a result of 
malaria, the disease accounts for 20% of all childhood deaths [3]. Malaria kills 3,000 children 
every day in sub-Saharan Africa—that is, a million a year [4]. 
In sub-Saharan Africa, many households, even children are familiar with malaria, where it 
has a reputation of causing teeth chattering chills, shakes and fever.  
Specific population risk groups include:  
• Young children in stable transmission areas who have not yet developed protective 
immunity against the most severe forms of the disease.  
• Non-immune pregnant women are at risk as malaria causes high rates of miscarriage 
(up to 60% in P. falciparum infection) and maternal death rates of 10–50%.  
• Semi-immune pregnant women in areas of high transmission. Malaria can result in 
miscarriage and low birth weight, especially during the first and second pregnancies. An 
estimated 200 000 infants die annually as a result of malaria infection during pregnancy.  
• Semi-immune HIV-infected pregnant women in stable transmission areas are at 
increased risk of malaria during all pregnancies. Women with malaria infection of the 
placenta also have a higher risk of passing HIV infection to their newborns.  
• People with HIV/AIDS are at increased risk of malaria disease when infected. 
• International travelers from non-endemic areas are at high risk of malaria and its 
consequences because they lack immunity.  
• Immigrants from endemic areas and their children living in non-endemic areas and 
returning to their home countries to visit friends and relatives are similarly at risk 






The following factors have made malaria a pending problem in sub-Saharan Africa. 
2. The malaria parasite 
Human Malaria is a parasitic disease caused by apicomplexan protozoan (single celled) 
coccidian. These parasites are haematozoans or haemosporinas of the family plasmodiidae. 
A contributing factor to the malaria problem in sub-Saharan Africa is the diversity of the 
parasite that infects humans. Four species infect man of which Plasmodium falciparium is the 
most virulent. The other species are P. vivax, P. malariae and P. ovale. P. falciparium and P. 
vivax are the most common [3]. 
In sub-Saharan Africa, P. falciparium poses the greatest threat because of its high level of 
mortality and the complications arising. P. vivax is worldwide in tropical and some 
temperate regions. P. vivax accounts for more than half of all malaria cases outside sub-
Saharan Africa. P. vivax is unique in that a sporozoite injected into the blood stream may 
stay in hepatocytes as hyponozoites. P. ovale is mainly in found in tropical West Africa and 
P. malariae is found worldwide but with patchy distribution [3]. These malaria parasites can 
develop within, invade red blood cells (erythrocytes) and consume up to 75% - 80% of their 
haemoglobin as nutrient source [1]. 
For both P. vivax and P. ovale, clinical relapses may occur weeks to months after the first 
infection, even if the patient has left the malarious area. These new episodes arise from 
"dormant" liver forms (absent in P. falciparum and P.malariae), and special treatment – 
targeted at these liver stages – is mandatory for a complete cure [3]. 
3. Complications of malaria 
P. falciparium causes severe complications as cerebral malaria, severe anaemia, acute renal 
failure, hypoglycemia and pulmonary infection. The two features that actually separate P. 
falciparium from the other human malaria are the ability to attack erythrocytes of all ages, 
causing high parasitaemia and enhanced growth and the capability to adhere to vascular 
endothelium through sequestration [2].  
P. falciparium is a threat because of high level of mortality and spreading drug resistance. 
Cerebral malaria caused by P. falciparium is when infected blood cells obstruct blood vessels 
in the brain; other vital organs can also be damaged often leading to death of patient.  
Malaria in pregnancy is widespread. Pregnant women are especially vulnerable because of 
iron deficiency, a special problem in malaria endemic areas .It endangers the health of women 
and prospects for the new born. Malaria causes anaemia and low birth weight babies. This is 
due to the loss of previously existing immunity. P. falciparium infects the Red Blood cells (RBC) 
that adheres to and accumulates in the placenta in pregnant women. Pregnancy exacerbates 
malaria through a nonspecific hormone-dependent depression of the Immune system. The 
protective antiplasmodial activity is suppressed at pregnancy, which has clinical consequences 
with important public health implications on pregnant women [2]. Malaria accounts for 6.5% 
of abortions, 15% of premature deliveries and 0.7% death in utero [3]. 
Malaria infection leads to increased morbidity and mortality and the delivery of premature 
infants with low birth weights due to intrauterine growth retardation (IUGR) that may have 
been as a result of placental parasitisation [2]. Malaria infection in pregnancy is significant in 
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sub -Saharan Africa where its fatality as a result of virulent P. falciparium is a far greater 
problem than in most parts of the world [4]. 
Anaemia is another malaria complication that can lead to death. It occurs when P. 
falciparium disrupts the erythrocytes and so decreases the production of erythrocytes. The 
pathology associated with P. falciparium malaria is in particular due to adherence of infected 
red blood cells in the brain causing metabolic disturbances and organ dysfunction [5].  
What of the devastating effect on children? Those children who succumb to the infection but 
survive are often left damaged. Recurrent infections can leave the child listless and with a 
poor appetite. It reduces social interaction, leading to poor development. Two percent of 
children who survive the cerebral form of the disease are left with learning difficulties and 
conditions such as spasticity and epilepsy [4]. 
4. The malaria vector 
Malaria is transmitted by the Anopheles mosquito which carries infective sporozoites stage in 
its salivary glands which it injects into the human blood stream during a blood meal. 
Several Anopheles mosquitoes have been incriminated as the major malaria vectors. About 20 
different Anopheles species are locally important around the world. The vector population in 
sub-Saharan Africa is uniquely effective, with the six species of the Anopheles gambiae 
complex being the most efficient vectors of human malaria in the region, and often 
considered the most important in the world [4]. An. funestus is also capable of producing 
very high inoculation rates in a wide range of geographic, seasonal, and ecological 
conditions. These vectors have proven effective in transmitting the malaria parasite to 
humans across the region, in rural and urban areas alike. An. pharoensis is also widely 
distributed in Africa, geographically and ecologically, and can maintain active transmission 
of malaria even in the absence of the main malaria vector.  
All of the important vector species bite at night. They breed in still waters or shallow 
collections of freshwater like puddles, rice fields, and hoof prints. Transmission is more intense 
in places where the mosquito is relatively long-lived (so that the parasite has time to complete 
its development inside the mosquito) and where it prefers to bite humans rather than other 
animals. For example, the long lifespan and strong human-biting habit of the African vector 
species is the underlying reason why more than 85% of the world's malaria deaths are in sub-
Saharan Africa [3]. Mosquito’s habits therefore determine the geographic spread of the disease.  
Malaria transmission is variable from one area to the other and this will impact on its 
epidemiology and control. In a study by Oyewole et al [7] in a coastal area of southern 
Nigeria in sub-Saharan Africa, several species of Anopheles mosquitoes occurred in 
sympatry. These species all combined to the transmission of malaria in the area. They were 
all competent vectors. For a mosquito to transmit malaria to man or other hosts the 
following points are crucial: 
i. Vector capacity and competence:  
Vectoral capacity has been used interchangeably to describe the ability of mosquitoes to 
serve as a disease vector. It is defined qualitatively and is influenced by such variables as 
vector density, longetivity and vector competence. Vectoral capacity takes into account 






between a vector, the pathogen transmitted by the vector and the vertebrate host to which 
the pathogen is transmitted [7]. 
Vector competence is a component of vectoral capacity and is governed by intrinsic and 
generic factors that influence the ability of a vector to transmit a pathogen. Susceptibility to 
sporozoite stage of Plasmodium species is an important component of vectoral competence. 
Vectors competence, however differ from one species to another and from place to place. 
There are vector species complexes that vary in their behaviors, vectorial capacities and 
competence and these present a real problem to malaria control. The main factor governing 
the ability of Anopheles specie to act as malaria vector is the frequency with which it feeds on 
humans. The vectors associated with stable malaria are those which are strongly 
antropophagic, often feeding on humans to the exclusion of other hosts. Anopheline vectors 
of malaria consists of various behavior associated with their biting activities and hence 
transmission dynamics [6].  
There is a considerable lack of information regarding vector habits, such as where Anopheles 
rest during the day, information that is critical for control efforts. Awolola et al. [8] reported 
that there is little information on sporozoite rates of Anopheles mosquitoes. This observation 
was the basis of several studies he carried out in Nigeria from 2003 – 2005. The paucity of 
data on species complexes and their bionomics hampers future vector control as an 
important component of malaria control.  
Correct analysis of the distribution of specific malaria vectors is one of the prerequisites for 
meaningful epidemiological studies and for planning and monitoring of successful malaria 
control or eradication programmes. Control measures can only be effective if the abundance, 
behaviour and proportion of the vectors are known. The existence of species complexes 
containing morphologically cryptic sibling or isomorphic forms presents a major challenge 
to malaria control programmes as these require vector identification using molecular 
techniques. Meanwhile, the distribution of the molecular M (Mopti) and S (Savannah) forms 
of An. gambiae s.s is still being determined for much of the West African regions [6, 8]. The 
malaria problem in sub-Saharan Africa represents a peculiar case because the vectoral 
system is the most complex anywhere.  
Beier [9] had suggested that malaria transmission dynamics is variable throughout Africa 
with huge variability in transmission patterns even within villages few kilometers apart. 
This vectoral system diversity impacts on malaria epidemiology and control. The An. 
gambiae complex is not the only vector in the field [6, 8]. Targeting only this species by 
whatever method is nonsense. The diversity of the epidemiological situation within sub- 
Saharan ecotypes presents differing malaria situation. Comprehensive knowledge of 
behaviour and heterogeneities that exist within, and among these vectors, will always be of 
benefit. Any strategy aiming at control will have to account for this heterogeneity.  
ii. Host preference:  
In some areas of sub-Saharan Africa people receive 200 to 300 infective bites per year [4]. 
This is another component of vectoral capacity and competence. The attractiveness of a 
blood meal host and the subsequent feeding success of a mosquito depend on characteristics 
such as host size, proximity to mosquito habitats, host abundance during mosquito host-
seeking periods, and host defense mechanisms [7, 8].  
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There can also be differences in host attractiveness for those mosquito species that feed on 
humans, and it is not uncommon for some people to be more attractive to mosquitoes than 
others. Studies have shown that humans appear to exude different amounts of the volatile 
compounds that mosquitoes loves. Scientists are currently studying the reasons for the 
difference in attractiveness in order to assist development of repellent compounds for 
preventing blood feeding and attractants for mosquito traps [10,11]. 
Some mosquito species may never attack man. Different mosquito species have evolved to 
blood feed on various types of vertebrate hosts. Some mosquitoes prefer mammalian blood, 
while others would rather feed solely on birds. There are even mosquitoes specialized to 
feed on amphibians or reptiles. Opportunistic feeding mosquitoes will feed on any animal, 
depending on host availability during the host-seeking period [10].  
Some Anopheles mosquitoes feed indoors and hence endophagic, while others feed outdoors 
hence exophagic. After blood feeding, some Anopheles mosquito may prefer to rest indoors 
hence are endophilic, while others prefer to rest outdoors hence exophilic. Some mosquito 
species search for hosts during daylight hours while others are active at dawn and dusk [10, 11]  
The main factor governing the ability of Anopheles specie to act as malaria vector is the 
frequency with which it feeds on humans. The vectors associated with stable malaria are 
those which are strongly antropophagic, often feeding on humans to the exclusion of other 
hosts. Anopheline vectors of malaria consists of various behavior associated with their 
biting activities and hence transmission dynamics [6].  
5. Human immunity 
This is another important factor, especially among adults in areas of moderate or intense 
transmission conditions. Immunity is developed over years of exposure, and while it never 
gives complete protection, it does reduce the risk that malaria infection will cause severe 
disease. For this reason, most malaria deaths in sub-Saharan Africa occur in young children, 
whereas in areas with less transmission and low immunity, all age groups are at risk [3].  
6. Climatic conditions 
Transmission also depends on climatic conditions that may affect the abundance and 
survival of mosquitoes, such as rainfall patterns, temperature and humidity. In many places, 
transmission is seasonal, with the peak during and just after the rainy season. Malaria 
epidemics can occur when climate and other conditions suddenly favour transmission in 
areas where people have little or no immunity to malaria. They can also occur when people 
with low immunity move into areas with intense malaria transmission, for instance to find 
work, or as refugees [3].  
7. Drug and vector resistances 
Treatment and control of malaria have become more difficult because of drug and vector 
resistances. Growing resistance to antimalarial medicines has spread very rapidly, undermining 
malaria control efforts. Chloroquine was introduced in the 1950s. When resistance to the drug 
developed in the 1970s, (Fansidar) sulphadoxine-pyrimethamine (SP) was introduced. 
Resistance to these drugs is now so high as to render them “virtually useless [12]. These 






increased treatment failure. There have also been reports of increasing multiple-drug resistance 
to drugs other than chloroquine, such as amodiaquine, mefloquine, rendering treatment of 
malaria even more problematic. Currently, the best available treatment, particularly for P. 
falciparium malaria, is artemisinin-based combination therapy (ACT) [3]. Artemisinin is part of a 
combination therapy that reduces or prevents the problem of drug resistance. 
Artemisinin and its derivatives like Artesunate, artemether, arteether and dihydroartemisin 
are the more common drugs now in sub- Saharan Africa. This is not surprising as there is 
currently no evidence for clinically relevant Artemisinin resistance. Nevertheless, Chloroquine 
and SP continue to be used because they cost around 10 US cents per treatment, whilst 
artemisinin combination treatment (ACT) costs US$1.50 per treatment. This is estimated to be 
an annual cost of between US$100 million and US$200 million a year [4]. 
When treated with an artemisinin-based monotherapy, patients may discontinue treatment 
early following the rapid clearance of malaria symptoms. This results in partial treatment 
and patients still have persistent parasites in their blood. Without a second drug given as 
part of a combination (as is done with an ACT), these resistant parasites survive and can be 
passed on to a mosquito and then another person. Monotherapies are therefore the primary 
force behind the spread of artemisinin resistance [3]. The limitations of these group of drugs 
are the short duration of antimalarial activity and high recrudescence rate. However, there is 
low toxicity and they are highly potent and rapidly metabolized [10].  
If resistance to artemisinin develops and spreads to other large geographical areas, as has 
happened before with chloroquine and (SP), the public health consequences could be dire, 
as no alternative antimalarial medicines will be available in the near future [3]. At least 300 
to 500 million malaria episodes are treated annually in sub-Saharan Africa. Moreover, many 
communities engage in preventive and treatment practices outside what is provided by 
"official” programs. 
Malaria vectors have shown resistance to numerous insecticides, including DDT, various 
organo-phosphates, and some carbamates. Mosquito control is being strengthened in many 
areas, but there are significant challenges, including:  
• an increasing mosquito resistance to insecticides, including DDT and pyrethroids, 
particularly in Africa; and  
• a lack of alternative, cost-effective and safe insecticides.  
The development of new, alternative insecticides is an expensive and long-term endeavour. 
Detection of insecticide resistance should be an essential component of all national malaria 
control efforts to ensure that the most effective vector control methods are being used [3].  
8. Socio economy aspects 
Malaria was a serious obstacle to the colonization of Africa. It caused a lot of suffering and 
tragedy. Its effect was devastating. It interfered with human progress and development. The 
disease is still a serious impediment to economic and social development in sub- Saharan Africa. 
The socio- economic aspects of a disease is a significant factor in the epidemiology and 
control of the disease. Malaria causes significant economic losses, and can decrease gross 
domestic product (GDP) by as much as 1.3% in countries with high levels of transmission. 
Over the long term, these aggregated annual losses have resulted in substantial differences 
in GDP between countries with and without malaria, particularly in Africa. 
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The health costs of malaria include both personal and public expenditures on prevention 
and treatment. In some heavy-burden countries, the disease accounts for: 
• up to 40% of public health expenditures;  
• 30% to 50% of inpatient hospital admissions;  
• up to 60% of outpatient health clinic visits. 
Malaria disproportionately affects poor people who cannot afford treatment or have limited 
access to health care, trapping families and communities in a downward spiral of poverty. 
Malaria is the commonest cause of work and school absenteeism in the tropics. It is the 
commonest cause of outpatient attendance in sub-Saharan Africa. Economic costs due to 
malaria are enormous if quantified [13].  
Socio economic consequences of diseases are better appreciated when expressed as loss of 
manpower. Poverty promotes malaria and malaria yields poverty. Socio economic cost can 
be measured in terms of absenteeism, drugs purchase, doctor’s fee, transport, and 
opportunity cost of time spent waiting for treatment. In Africa alone, the estimated annual 
direct and indirect costs of malaria were US$800 million in 1987 and exceeded US$1800 
million by 1995. Malaria undermines the health and welfare of families, endangers the 
survival and education of children, debilitates the active population and impoverishes 
individuals and countries. It is one of the most serious obstacles to mankind’s effort to 
develop agriculture, settlement, development projects and irrigation 
Knowledge, attitudes and practices are essential for control programmes. Without the 
rational concept of the cause of a disease, it is impossible to design control programmes. 
There still exist wrong misconceptions of malaria in sub Saharan Africa. 
Women bear more brute of the disease than men in sub-Saharan Africa. They often tolerate 
symptoms of malaria until they are critically ill because of the perception that sick women 
are mean or lazy. Women are reproached when there are malaria epidemics for having 
failed as custodians of health. Women are increasingly been informed to help them 
recognize the symptoms of malaria in themselves and family members e.g., fever chills, 
headache. When children are sick from malaria, women usually bear the psychological 
effects. Severe convulsions, fever and other symptoms affecting children leave a 
psychological effect of fear and restlessness on the mothers [14]. 
9. Conclusion 
Malaria in sub-Saharan Africa is a problem of dimensions unlike malaria seen anywhere else 
in the world today [13]. The magnitude of malaria is affected by a variety of factors, none of 
which addressed alone is likely to effect a resolution. It is further compounded by the 
generally poor social and economic conditions in sub-Saharan Africa. 
Malaria could be brought under control in sub-Saharan Africa as it has been in Europe and 
America. Instead, it is being allowed to run out of control just like the AIDS epidemic 
because of the indifference of Western governments to the lives of the poorest people on the 
planet [15]. 
Poor people who represent most of the continent’s malaria disease burden cannot afford to 
pay much more than what they currently pay for the old treatments, so costs must be 






is political will. Unless this situation changes, people will continue to die needlessly from 
taking drugs that no longer work. 
Malaria has therefore remained a deadly scourge and pending problem in Africa and is a yet 
to be conquered disease.  
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